Control of porphyria cutanea tarda with anti-IL-17 secukinumab in a person with psoriasis living with HIV
Looking at the treatment of porphyria cutanea tarda in a person living with HIV.
View PublicationLooking at the treatment of porphyria cutanea tarda in a person living with HIV.
View PublicationExamining the global prevalence of chronic pain in women with HIV
View PublicationExamining the risk of hospitalization within 14 days of COVID-19 diagnosis among people living with HIV (PLWH) and HIV-negative individuals who had laboratory-confirmed SARS-CoV-2 infection.
View PublicationLooking at bone mineral density in women living with HIV.
View PublicationConsidering the prevalence of HPgV in a cohort of HCV/HIV co-infected patients undergoing treatment for HCV with direct acting antivirals (DAA) and investigate the effect of DAA therapy on HPgV infection.
View PublicationConsidering temporal changes in plasma proteins following SARS-CoV-2 infection and pre-infection proteomic markers associated with future COVID-19
View PublicationConsidering the effects of host factors and COVID-19 on the humoral repertoire in people living with HIV.
View PublicationConsidering the impact of COVID-19 on Two-Spirit, lesbian, gay, bisexual, transgender, and queer (2SLGBTQ+) populations in Canada
View PublicationConsidering the relationship between inflammasome activation and coronary plaque.
View PublicationDiscussing cognitive remediation group therapy as an in-person intervention for people aging with HIV
View Publication